Jun
2026
Shanghai New International Expo Center
Visit us
stand E7E02, Contract Services

Senova Technology Company Limited

Exhibitor at CPHI & PMEC China 2026
About Us

Senova means“Sep With Innovation", we are a professional company who's supplying APIs(mainly New Generics), Advanced Intermediates and KSM(Key Starting Materials) as well as technical Support/Registration support/Custom synthesis service in pharmaceutical and related field , we focus on serving those manufacturers' New Generics Projects from R&D stage to Commercial Stage from meterials to documents support(DMF/CMC). For those regulated markets, we secure all of our products can be produced under GMP regulation with Full Documentation.

Read more Show less
Products
Show more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    China
  • On CPHI since:
    2023
  • Employees:
    100 - 249
Company types
Biopharmaceutical company
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI & PMEC China 2026
  • 16 Jun 2026 - 18 Jun 2026
  • Shanghai New International Expo Center
  • Visit us at stand E7E02, Contract Services

Products Featured at CPHI & PMEC China 2026

  • Semaglutide

    Product Semaglutide

    Semaglutide(910463-68-2) is an anti-diabetic medication that is sold under brand names such as Ozempic, Wegovy, and Rybelsus. It is used to treat type 2 diabetes and manage chronic weight. The drug functions similar to human glucagon-like peptide-1 (GLP-1) by increasing insulin secretion, which leads to im...
  • Tirzepatide

    Product Tirzepatide

    Tirzepatide (LY3298176) was developed as a dual agonist to both GLP-1 and gastric inhibitory polypeptide (GIP) receptors (Frias et al., 2018). Similar to GLP-1, GIP is an incretin hormone that functions to induce insulin secretion.
  • Mazdutide

    Product Mazdutide

    Mazdutide is a co-agonist of glucagon-like peptide (GLP-1R) and glucagon receptor (GCGR)
  • Survodutide

    Product Survodutide

    Survodutide is a potent, selective glucagon receptor/GLP-1 receptor (GCGR/GLP-1R) dual agonist
  • Linaclotide

    Product Linaclotide

    Linaclotide, a synthetic peptide structure containing 14 amino acids related to the endogenous guanosine peptide family, is the only FDA-approved clinically available intestinal topical-acting GC-ChemicalbookC (guanylate cyclase-C) agonist analog for the treatment of constipated irritable bowel syndrome (I...